← The Wire
MBXNasdaq
MBX Biosciences, Inc.
Pharmaceutical Preparations · DE · CIK 1776111
MBX Biosciences develops precision peptide therapies for endocrine and metabolic disorders using its PEP platform
red 8-K · 90d
$1.69B
Market cap
$53.85
Last close
+2.9%
1D
+22.6%
5D
1.2M
Volume
Price · last 39 sessions+82.9%
May 4L $29.00 · H $53.85Jun 29
50
Total filings
Jun 12, 2026
Last filing
12/31
Fiscal year end
8-KReg FD Disclosure · Company UpdateJun 12, 20268-KExecutive Change · Shareholder VoteJun 5, 20268-KReg FD Disclosure · Company UpdateMay 11, 2026DEFA14ADEFA14AMay 8, 20268-KResults of OperationsMay 7, 202610-Q10-QMay 7, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 202610-K10-KMar 12, 20268-KResults of OperationsMar 12, 20268-KReg FD Disclosure · Company UpdateMar 9, 20268-KExecutive Change · Material AgreementFeb 27, 2026SC 13D/ASC 13D/AFeb 11, 20268-KCompany UpdateFeb 5, 20268-KExecutive Change · Reg FD DisclosureJan 22, 20268-KResults of Operations · Reg FD DisclosureJan 12, 202610-Q10-QNov 6, 20258-KExecutive Change · Results of OperationsNov 6, 20258-KMaterial AgreementSep 26, 2025424B4424B4Sep 25, 2025S-1S-1Sep 22, 20258-KReg FD Disclosure · Company UpdateSep 22, 20258-KReg FD Disclosure · Company UpdateSep 4, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KReg FD Disclosure · Company UpdateJun 16, 20258-KReg FD DisclosureJun 9, 20258-KExecutive Change · Shareholder VoteJun 6, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 2025DEFA14ADEFA14AApr 23, 2025DEF 14ADEF 14AApr 23, 20258-KExecutive Change · Reg FD DisclosureApr 7, 202510-K10-KMar 17, 20258-KResults of OperationsMar 17, 20258-KResults of Operations · Reg FD DisclosureJan 7, 2025SC 13GSEC SCHEDULE 13GNov 8, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13GSC 13GNov 1, 2024SC 13DSC 13DSep 23, 2024SC 13DNEW ENTERPRISE ASSOCIATES 17, L.P. -- MBX BIOSCIENCES, INC. 13DSep 23, 2024SC 13DSCHEDULE 13DSep 23, 2024SC 13GSC 13GSep 23, 2024SC 13DSC 13DSep 23, 2024SC 13GSEC SCHEDULE 13GSep 20, 20248-KBylaw AmendmentSep 16, 2024424B5424B5Sep 13, 2024S-1/AS-1/ASep 9, 2024S-1/AS-1/AAug 30, 2024S-1S-1Aug 23, 2024
Insider Activity
In the 90 days to Mar 13, 2026: 1 insider bought $526K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2026 | Hawryluk P. KentPresident & CEO | Buy | 18,500 | $28.41 | $526K |
| Oct 20, 2025 | Hawryluk P. KentPresident & CEO | Buy | 20,000 | $13.64 | $273K |
| Oct 17, 2025 | Hoerter Steven L.Director | Buy | 20,000 | $13.25 | $265K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance